Clinical Trials Browser

Phase 1/2 × HER2 Positive Advanced Solid Tumors × fludarabine × Clear all

NCT05681650 2023-12-12

HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

HER2 Positive Advanced Solid Tumors